Literature DB >> 1981485

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in goldfish brain.

A Poli1, T Guarnieri, F Facchinetti, L Villani.   

Abstract

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which selectively damages dopaminergic neurons in mammals, caused a marked depletion of tyrosine hydroxylase (TH) immunoreactivity in the goldfish brain. The concomitant ultrastructural observations showed the neurotoxic effect of MPTP on telencephalic, diencephalic and medullar neurons. The affected neurons revealed darkening of the cytoplasm and swelling of the mitochondria and the endoplasmic reticulum. Concomitant significant decreases in dopamine (DA) and noradrenaline (NA) levels were determined in the brain areas where morphological observations were performed. The loss of catecholamine levels was completely prevented by the treatment with the monoamine oxidase (MAO) inhibitor pargyline to prevent MPTP oxidation. The results indicate that in goldfish brain, acute MPTP administration causes selective catecholamine depletion, without altering the serotoninergic system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981485     DOI: 10.1016/0006-8993(90)90110-w

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Effects of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment on ovarian development of the sapphire devil, Chrysiptera cyanea.

Authors:  Muhammad Badruzzaman; Satoshi Imamura; Yuki Takeuchi; Taro Ikegami; Akihiro Takemura
Journal:  Fish Physiol Biochem       Date:  2014-11-02       Impact factor: 2.794

2.  MPTP-induced apoptosis in the retina of goldfish.

Authors:  L Villani; A Beraudi; A Giuliani; A Poli
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

3.  Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains.

Authors:  Stéphanie Baulac; Hope Lu; Jennifer Strahle; Ting Yang; Matthew S Goldberg; Jie Shen; Michael G Schlossmacher; Cynthia A Lemere; Qun Lu; Weiming Xia
Journal:  Mol Neurodegener       Date:  2009-02-25       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.